Xie, S., Chen, J., Li, Z., Luo, W., Zhong, S., & Lai, W. (2025). Levo-corydalmine derived from Rhizoma Corydalis suppresses Ox-LDL-induced endothelial cell activation and improves vasodilatation by regulating the DDIT3-eNOS pathway. Naunyn-Schmiedeberg's Archives of Pharmacology, 1-18. https://doi.org/10.1007/s00210-025-04110-1
Chicago-referens (17:e uppl.)Xie, Shaoxia, Jiajie Chen, Zhuoming Li, Wenwei Luo, Shilong Zhong, och Weihua Lai. "Levo-corydalmine Derived from Rhizoma Corydalis Suppresses Ox-LDL-induced Endothelial Cell Activation and Improves Vasodilatation by Regulating the DDIT3-eNOS Pathway." Naunyn-Schmiedeberg's Archives of Pharmacology 2025: 1-18. https://doi.org/10.1007/s00210-025-04110-1.
MLA-referens (9:e uppl.)Xie, Shaoxia, et al. "Levo-corydalmine Derived from Rhizoma Corydalis Suppresses Ox-LDL-induced Endothelial Cell Activation and Improves Vasodilatation by Regulating the DDIT3-eNOS Pathway." Naunyn-Schmiedeberg's Archives of Pharmacology, 2025, pp. 1-18, https://doi.org/10.1007/s00210-025-04110-1.
